{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:41:01Z","timestamp":1772131261406,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12350-021-02780-x","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T16:03:04Z","timestamp":1631203384000},"page":"2460-2470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Vaiibhav N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin A.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Poitrasson-Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kopin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cascino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh L.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Koelling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10 Pt 1","key":"10.1007\/s12350-021-02780-x_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"7-8","key":"10.1007\/s12350-021-02780-x_bib2","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"issue":"6","key":"10.1007\/s12350-021-02780-x_bib3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"issue":"1","key":"10.1007\/s12350-021-02780-x_bib4","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"7","key":"10.1007\/s12350-021-02780-x_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1007\/s12350-021-02780-x_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1007\/s12350-021-02780-x_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2 Pt 2","key":"10.1007\/s12350-021-02780-x_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02780-x_bib9","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"issue":"7","key":"10.1007\/s12350-021-02780-x_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1007\/s12350-021-02780-x_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12350-019-01786-w","article-title":"Characterization of a highly effective preparation for suppression of myocardial glucose utilization","volume":"27","author":"Larson","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1007\/s12350-021-02780-x_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1007\/s12350-021-02780-x_bib13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.amjcard.2009.12.072","article-title":"Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening","volume":"105","author":"Banko","year":"2010","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1007\/s12350-021-02780-x_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"18","key":"10.1007\/s12350-021-02780-x_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1007\/s12350-021-02780-x_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1007\/s12350-021-02780-x_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1007\/s12350-021-02780-x_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J Card Fail"},{"issue":"1","key":"10.1007\/s12350-021-02780-x_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1007\/s12350-021-02780-x_bib20","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"issue":"4","key":"10.1007\/s12350-021-02780-x_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","article-title":"Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device","volume":"18","author":"Winters","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1007\/s12350-021-02780-x_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1007\/s12350-021-02780-x_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","journal-title":"Clin Cardiol"},{"issue":"9","key":"10.1007\/s12350-021-02780-x_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis","volume":"9","author":"Disertori","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1007\/s12350-021-02780-x_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1007\/s12350-021-02780-x_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9343(88)80340-1","article-title":"Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis","volume":"85","author":"Tellier","year":"1988","journal-title":"Am J Med"},{"issue":"3","key":"10.1007\/s12350-021-02780-x_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1007\/s12350-021-02780-x_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1007\/s12350-021-02780-x_bib29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1007\/s12350-021-02780-x_bib30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1007\/s12350-021-02780-x_bib31","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1007\/s12350-021-02780-x_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1007\/s12350-021-02780-x_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02780-x_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2020.04.041","article-title":"Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis","volume":"313","author":"Yodogawa","year":"2020","journal-title":"Int J Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02780-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-021-02780-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123005664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123005664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02780-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:57Z","timestamp":1761027117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123005664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1071358123005664"],"URL":"https:\/\/doi.org\/10.1007\/s12350-021-02780-x","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-021-02780-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}